Ironwood Pharmaceuticals Overview

Life ScienceCompany

Where is Ironwood Pharmaceuticals headquartered?

Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.

What is Ironwood Pharmaceuticals’ revenue?

Ironwood Pharmaceuticals disclosed revenue of 351M USD for 2024 and 443M USD for 2023.

How many employees does Ironwood Pharmaceuticals have?

Ironwood Pharmaceuticals has 253 employees.

What sector is Ironwood Pharmaceuticals in?

Ironwood Pharmaceuticals is a life science company.

When was Ironwood Pharmaceuticals founded?

Ironwood Pharmaceuticals was founded in 1998.

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals, Inc.

100 Summer Street, Suite 2300,
Boston, Massachusetts 02110
United States,
(617) 621-7722
www.ironwoodpharma.com

Ironwood Pharmaceuticals is a healthcare company, that focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. Ironwood Pharmaceuticals was founded in 1998 and is based in Boston, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - - - 1 - - 1
vol $1.0B $1.0B
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Financial Deals
J.P. Morgan Securities
1
RBC Capital Markets
1
Citi
1
Legal Deals
Latham & Watkins
1
Advestra
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.